TY - JOUR
T1 - Novel HBsAg markers tightly correlate with occult HBV infection and strongly affect HBsAg detection
AU - Svicher, Valentina
AU - Cento, Valeria
AU - Bernassola, Martina
AU - Neumann-Fraune, Maria
AU - Hemert, Formijn Van
AU - Chen, Mengjie
AU - Salpini, Romina
AU - Liu, Chang
AU - Longo, Roberta
AU - Visca, Michela
AU - Romano, Sara
AU - Micheli, Valeria
AU - Bertoli, Ada
AU - Gori, Caterina
AU - Ceccherini-Silberstein, Francesca
AU - Sarrecchia, Cesare
AU - Andreoni, Massimo
AU - Angelico, Mario
AU - Ursitti, Antonella
AU - Spanò, Alberto
AU - Zhang, Jing Maria
AU - Verheyen, Jens
AU - Cappiello, Giuseppina
AU - Perno, Carlo Federico
PY - 2012/1
Y1 - 2012/1
N2 - Occult HBV infection (OBI) is a threat for the safety of blood-supply, and has been associated with the onset of HBV-related hepatocellular carcinoma and lymphomagenesis. Nevertheless, genetic markers in HBsAg (particularly in D-genotype, the most common in Europe) significantly associated with OBI in vivo are missing. Thus, the goal of this study is to define: (i) prevalence and clinical profile of OBI among blood-donors; (ii) HBsAg-mutations associated with OBI; (iii) their impact on HBsAg-detection. OBI was searched among 422,278 blood-donors screened by Nucleic-Acid-Testing. Following Taormina-OBI-definition, 26 (0.006%) OBI-patients were identified. Despite viremia
AB - Occult HBV infection (OBI) is a threat for the safety of blood-supply, and has been associated with the onset of HBV-related hepatocellular carcinoma and lymphomagenesis. Nevertheless, genetic markers in HBsAg (particularly in D-genotype, the most common in Europe) significantly associated with OBI in vivo are missing. Thus, the goal of this study is to define: (i) prevalence and clinical profile of OBI among blood-donors; (ii) HBsAg-mutations associated with OBI; (iii) their impact on HBsAg-detection. OBI was searched among 422,278 blood-donors screened by Nucleic-Acid-Testing. Following Taormina-OBI-definition, 26 (0.006%) OBI-patients were identified. Despite viremia
KW - HBsAg detection
KW - HBsAg structure
KW - HBV
KW - Occult infection
UR - http://www.scopus.com/inward/record.url?scp=84355161480&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84355161480&partnerID=8YFLogxK
U2 - 10.1016/j.antiviral.2011.10.022
DO - 10.1016/j.antiviral.2011.10.022
M3 - Article
C2 - 22086128
AN - SCOPUS:84355161480
SN - 0166-3542
VL - 93
SP - 86
EP - 93
JO - Antiviral Research
JF - Antiviral Research
IS - 1
ER -